Organ Donation & ...
Follow
Find tag "treatment"
5.8K views | +0 today
Organ Donation & Transplant Matters Resources
Combining reports, research findings and topic reviews
Curated by Deborah Verran
Your new post is loading...
Your new post is loading...
Scooped by Deborah Verran
Scoop.it!

Drugs produce high hepatitis C eradication rates, even in patients with liver disease

Drugs produce high hepatitis C eradication rates, even in patients with liver disease | Organ Donation & Transplant Matters Resources | Scoop.it

This is the latest report of success being achieved with new direct anti-viral drugs in the treatment of hepatitis C.

 

Two clinical trials of antiviral drug combinations report that 12-week courses are leading to effective viral eradication for a high percentage of patients with chronic hepatitis C infection.

 

To read more on the particular drugs involved and what the exact results were please click on the banner headline.

Deborah Verran's insight:

Further evidence of the efficacy of some of the new antiviral agents for treating chronic hepatitis C. It is hoped that eventually there will be less patients requiring liver transplantation for liver disease due to this particular virus.

more...
No comment yet.
Scooped by Deborah Verran
Scoop.it!

Mechanism helps explain persistence of hepatitis C virus but new treatments on the horizon

Mechanism helps explain persistence of hepatitis C virus but new treatments on the horizon | Organ Donation & Transplant Matters Resources | Scoop.it

The first part of this post is the news that researchers at the University of California, San Diego School of Medicine have identified a mechanism that explains why people with the hepatitis C virus get liver disease. Plus this may be why the virus is able to evade the normal mechanisms in the body that eradicate similar viral pathogens. For more on this story click

on the banner headline.

 

The second part is news on some of the new antiviral combinations which appear promising for the treatment of hepatitis C. For more on this click on either of the following links-

 

http://www.medicalnewstoday.com/releases/275472.php#.U057niNk8H8.twitter

 

http://www.medicalnewstoday.com/releases/275468.php

 

 

 

Deborah Verran's insight:

With hepatitis C being the most common indication for liver transplantation in many countries, any progress in either the understanding of how the virus causes liver disease or in treating this virus is extremely important

more...
No comment yet.
Scooped by Deborah Verran
Scoop.it!

Kidney transplant patients live longer than those in intensive home hemodialysis - Medical Xpress

Kidney transplant patients live longer than those in intensive home hemodialysis - Medical Xpress | Organ Donation & Transplant Matters Resources | Scoop.it

Analysis of data from a research study performed in Canada has revealed that Kidney transplant patients live longer than those receiving intensive home hemodialysis.

 

A first-ever study from a large Canadian centre has found that kidney

transplant recipients lived longer and had better treatment success regardless of what type of donor kidney that they received. 'Kidney transplant is still the best treatment option says Dr Chris Chan (pictured) who is a nephrologist at the Toronto General Hospital.

 

To read more about the findings of this study, click on the banner headline.

more...
No comment yet.
Scooped by Deborah Verran
Scoop.it!

New antiviral treatment could significantly reduce global burden of hepatitis C - University of Bristol

New antiviral treatment could significantly reduce global burden of hepatitis C - University of Bristol | Organ Donation & Transplant Matters Resources | Scoop.it

New antiviral treatment could significantly reduce global burden of hepatitis C University of Bristol Findings, published in Hepatology, reveal the impact of a new antiviral treatment that could potentially reduce HCV rates in some cities affected around the world (including in the United Kingdom and Australia)...

 

The challenge is to lift the rates of treatment of chronic hepatitis C such that the rates of chronic liver disease requiring ongoing medical treatment are then subsequently reduced

 

Deborah Verran's insight:

With chronic hepatitis C being the current leading underlying disease indication for liver transplantation, implementing effective strategies to treat hepatitis C will become increasingly important.

more...
No comment yet.